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Recipients of hemopoietic transplants are usually preexposed to whole body 
irradiation to deplete the blood-forming system, and so provide the transferred 
cells with a "graft bed" and stimuli for maximal proliferation and differentia- 
tion. It is generally assumed that irradiation in the lethal dose range would 
also be immunosuppressive and enable allogeneic cells to engraft. This assump- 
tion, however, is not correct. In the course of studies on the genetics of hybrid 
resistance to parental bone marrow grafts, it was noted that allografts did not 
establish  themselves in irradiated  hosts  of  certain mouse strains  while suc- 
ceeding in hosts of other strains (1). The mice in which marrow grafts grew and 
those  in  which  the  same  cells  failed sometimes belonged  to  inbred  strains 
sharing the same//-2 alleles. This suggested that genes other than those specify- 
ing major  transplantation  antigens  influenced the  outcome of marrow  allo- 
grafts in irradiated mice. Additional evidence is now presented in support of 
this view. The data also indicate that a  peculiar type of incompatibility for 
hemopoietic allografts is common in irradiated mice, and that it results from 
destructive host anti-graft reactions. Since the processes of cellular prolifera- 
tion, antibody formation, and skin graft rejection are impaired after whole body 
irradiation, bone marrow allografts are presumably rejected by a  mechanism 
previously unknown. This type of aUograft reaction is peculiar because it does 
not require proliferation of lymphoid cells and is tissue specific,  thymus inde- 
pendent, and regulated by genetic factors which apparently do not affect the 
fate of other solid grafts. 
Materials and Methods 
Mice.--Most inbred and F1 strains were raised in our animal colony, and were derived from 
pedigreed breeders supplied by G. D. Snell, Jackson Laboratory, Bar Harbor, Maine (C57BL/ 
10ScSn [abbreviated  B10], C3H.SW,  B10.D2, A.BY),  E.  S.  Russell,  Jackson  Laboratory 
* Research  supported  by U.S. Public Health Service grant AM-13,969 from the Institute 
of Arthritis  and  Metabolic  Diseases, by American Cancer Society grant T-476, and  by con- 
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(WB/Re), J. H. Stimpfling, Columbus Hospital, Great Falls, Mont.  (B10.BR, B10.A),  and 
T. S. Hauschka, Roswell Park Memorial Institute, Buffalo, N. Y. (129/Rr, C3H/He, C3H/St, 
C57BL, A/He, DBA/2Ha). (C3H/HexB10)F1 mice (abbreviated C3BF1) were obtained from 
the West Seneca Animal Production  Unit of Roswell Park  Memorial Institute;  C57BL/6, 
DBA/2J, and  (C57BL/6JxDBA/2J)F1  (abbreviated BDF1) mice from the Jackson Labora- 
tory; AKR, BALB/c, DBA/2Cum, (BALB/cxDBA/2)F1, and 101-strain  mice from Cumber- 
land View Farms, Clinton, Tenn. Mice of both sexes,  10-15 wk old, were used in most experi- 
ments. F1 hybrids were designated by listing first the female and then the male parental strain. 
Irradiation.--Mice to be grafted with marrow cells were exposed  to  700-900  R  of total 
body X-irradiation as described elsewhere  (2). 
Thymectomy.--The thymus of the adult mouse was aspirated with a suction pipette through 
an incision in the anterior chest,  according to the method described by Miller (3).  Control 
mice were sham operated. The effectiveness of thymectomy was controlled by determining the 
number of graft-versus-host cells in spleens  of mice sampled from each group  (4). 
Immunization.--Mice were given 107 viable spleen cells from It-2-incompatible donors  by 
intraperitoneal injection. All animals were immunized twice at 7-day intervals and used as 
graft recipients 4-7 days after the last injection. 
Cell Suspensions and Transplantation.--Nucleated  bone marrow cells, suspended in Eagle's 
medium, were counted and injected into a lateral tail vein of irradiated mice as  previously 
described (2, 5). 
A ssayfor Proliferation of Grafted Cells.--5-iodo-2'-deoxyuridine  (IUdR)I labeled with radio- 
active  125I was used to assess  DNA synthesis in spleens of irradiated mice grafted with bone 
marrow cells.  Details of the method were previously described  (2, 5). Briefly, mice were in- 
jected with the radioactive DNA precursor 4 or 5 days after transplantation, and the per cent 
retained  in  individual  spleens was  determined  by  measuring  radioactivity with  a  crystal 
scintillation counter. The values of IUdR uptake were expressed as arithmetic or geometric 
means 4- standard errors for groups of 4-10 spleens,  above the values of control spleens.  Con- 
trols were irradiated  mice not injected with marrow cells; the uptake values of IUdR were 
not greater  than  0.03%  in such  spleens.  The numbers  of marrow cells to be grafted  were 
chosen from within the range of linear dose-response  relationship, yielding uptake values of 
IUdR of 0.3-1.0% in syngeneic hosts. 
RESULTS 
Marrow Graft  Failures in Irradiated Mice.--5  X  105-106 nucleated marrow 
cells from B 10, DBA/2Ha,  or C3H donors were transplanted into syngeneic and 
allogeneic  recipients,  2-4  hr  after  700-900  R  of X-rays.  The  allogeneic  mice 
were  chosen  so  that  cells  of  each  donor  were  grafted  into  recipients  sharing 
the donor's H-2 allele (//-2-compatible strains)  and into recipients with different 
H-2  alleles  (H-2-incompatible  strains).  The  latter  belonged  to  sets  of  two  or 
more strains of mice with identical H-2 alleles; in this way genetic factors other 
than  H-2 could  vary within  each  set  while the  host-donor  relationships  with 
respect  to H-2  did  not.  Whenever  possible,  the  sets  of  H-2-incompatible  re- 
cipients included mice of a strain congenic (6) with the donor strain for an allelic 
substitution  at the H-2 locus. These different combinations m~de it pgssible to 
observe  the  outcome  of marrow  allografts  in  recipients  differing  at  several H 
1  Abbreviations used in this paper:  ALS, rabbit  anti-mouse thymocyte serum; C¥, cyclo- 
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loci except It-2, at H-2 and other H  loci, and at the It-2 locus only, under the 
influence  of  the  other  genes  belonging  to  different  genetic  "backgrounds." 
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FIG.  1.  Proliferation of transplanted marrow  ceils in syngeneic  or allogeneic irradiated 
recipients. Proliferation was estimated 5 days after transplantation of 0.5-1  X  106 cells by 
measuring splenic retention of the DNA precursor IUdR. Each group of recipients included a 
minimum  of 10 female and 10 male mice grafted in two or more separate experiments.  Stan- 
dard errors of mean values of isotope uptake were 10% or less. Results in DBA/2J, DBA/2Ha, 
and DBA/2Cum recipients were indistinguishable and, therefore, pooled. 
Repopulation of recipient spleens by dividing hemopoietic cells of donor origin 
was  assessed  on  day  5  after  transplantation.  The  results  are  presented  in 
Fig. 1. 
The  mean  splenic uptake values of IUdR  were  similar in  syngeneic and in 86  ]REJECTION  OF BONE  M_ARROW ALLOGRAFTS 
H-2-compatible allogeneic mice grafted with marrow cells. This indicated that 
growth of donor cells was not impaired by host-donor differences at loci other 
than 1t-2.  Recipient mice of this  type were  called  "susceptible" to  marrow 
allografts. In H-2-incompatible recipients, splenic IUdR uptake values varied 
according to strain but not to H-2 type. In each set of H-2-incompatible hosts 
(e .g.,  AKR,  C3H,  101, C57BR,  and B10.BR mice, which were all H-2  k  and 
grafted with B 10 cells), IUdR uptake values ranged from ~-~0.60  %, just below, 
or at the values seen in syngeneic recipients, to 0.01%, the value seen in radia- 
tion controls. These H-2-incompatible recipients could be classified as resistant, 
partially resistant,  or susceptible,  depending  on the 5  day growth  of trans- 
planted marrow. Except for grafts of B 10 marrow cells into DBA/2 recipients, 
the  sexes  of donor  and  recipient mice had  no  detectable influence on  graft 
proliferation. For this reason the data were not presented separately, although 
mice of both sexes were used in all experiments. Mice resistant to grafts of one 
H-2 type could be partially resistant or even susceptible to grafts of a second 
type; B10 mice were resistant to DBA/2 but not to C3H grafts,  and DBA/2 
mice were resistant to B10, but not to C3H grafts. Resistance was not neces- 
sarily reciprocal in host-donor pairs; B10 mice were not resistant to B 10.BR 
grafts, although B10.BR mice were resistant to B10 grafts (data not shown in 
Fig.  1). On the other hand, resistance was reciprocal in mice of the B10 and 
B10.D2 pair. 
Five different matings between susceptible and resistant mice with identical 
H-2 alleles were set up to produce H-2-homozygous F1 hybrids. The F1 mice 
were  given  the  appropriate  test  grafts  to  determine  whether  resistance  or 
susceptibility would be the dominant inherited trait. Resistance appeared to be 
phenotypicaUy dominant since the splenic uptake values of IUdR were negli- 
gible in all F1 mice (Fig.  1). Reciprocal hybrids of both sexes,  e.g. female and 
male,  (C3H/He x  B10.BR)F1  and  (B10.BR x  C3H/He)F1 mice were indis- 
tilaguishable. 
Maturation of Resistance  to Marrow Allografts in Infant Mice.--The failure of 
transplanted marrow cells to proliferate in resistant hosts could have been due 
to localized graft~versus-host  reactions (7) or to allogeneic inhibition (8). If so. 
infant recipients should be at least as resistant as adults, since they are regarded 
as  the  most  sensitive indicators  of graft-versus-host  reactions  and  are  fully 
antigenic.  5  X  105 marrow cells  of B10  donors were infused into irradiated 
(600 R)  syngeneic and  allogeneic recipients  that  were  15-22  days  old.  The 
infant  mice  were  left with  their  mothers  after  transplantation.  B10.A  and 
B10.D2 recipient mice, which were resistant to B10 cells as adults (Fig. 1), were 
susceptible at  15,  17,  and 20 days of age;  they became resistant  on day 22 
(Table I).  129-strain mice were susceptible as adults  and at 22  days of age. 
The results indicated that resistance was a host function subject to maturation 
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marrow graft failure in adult mice resulted from graft-versus-host  reactivity or 
from allogeneic inhibition, i.e., the incongruence of donor and host cell surfaces 
with different H-2 alloantigens. 
Weakening  of Resistance  to  Marrow  Allografts  with  Cydophosphamide.--Be- 
cause of the late maturation of resistance in infant mice, it is possible that the 
failure of marrow grafts in adult mice was due to host anti-graft reactions. If so, 
the  effector mechanisms for rejection  of bone marrow and  solid tissue  grafts 
must differ, since only the former was not radiosensitive and, presumably, did 
not require  cell proliferation  during induction.  To investigate this possibility, 
TABLE I 
Uptake of IUdR in Spleens of Irradiated Infant Mice 5 Days after Grafting 
5 X  10  ~ Bone Marrow Cells of BIO Donors* 
Mean splenic uptake of  Recipient strain  Age  Number and sex of mice  l~SlUdR~: 
(days)  (F)  (M)  (% 4- sz) 
B10  15  2  4  0.76  4- 0.04 
B10.A  16  2  7  0.67  4- 0.03 
B10.D2  17  2  1  0.55  4-  0.06 
B10  21  2  5  0.45  4-  0.03 
129  22  2  4  0.42  4- 0.07 
B10.A  20  3  3  0.36  4- 0.08 
B10.A  22  6  2  0.08  4- 0.01 
B10.D2  22  2  5  0.01  4-  0.004 
* Infant mice were exposed to 600 R of X-rays and returned  to their mothers regardless 
of age. 
:~ Mean  radiation  control  values  (~0.02%)  were subtracted  from  each  experimental 
value. 
resistant mice were subjected to immunosuppressive treatment before challenge 
with the appropriate  allografts.  Cyclophosphamide was chosen because  of its 
prior use for the induction of hemopoietic chimerism in mice (9-11). 
Cyclophosphamide  (Cytoxan,  Mead  Johnson  &  Co.,  Evansville,  Ind.,  ab- 
breviated  CY)  was injected  intraperitoneaUy,  300 mg/kg of body weight,  at 
varying intervals before irradiation  (800 R  to inbred strain mice and 900 R  to 
F1 hybrids)  and transplantation  of 1.3-3.0  X  106 marrow cells.  Control mice 
received injections of saline without CY. The intervals were never shorter than 
1 day to avoid cytotoxic effects of the drug on the grafted cells. Rep0pulation 
of recipient spleens was assessed 4 days after cell injections; in each experiment 
one  group  of  mice  was  treated  with  CY,  irradiated,  but  not  injected  with 
marrow cells to determine  the background level of splenic retention of IUdR. 
Other groups of mice were treated with CY, irradiated,  and grafted with syn- 88  REJECTION  OF  BONE  MARROW  ALLOGRAFTS 
geneic instead of allogeneic cells to determine whether  CY influenced grafted 
cell proliferation in the  absence of histoincompatibility. The results are pre- 
sented in Table II. 
B10,  DBA/2,  and  B10.D2  marrow  cells  grew  approximately  the  same  in 
syngeneic mice injected either with  saline or  with  CY,  1  or  12  days before 
TABLE  II 
Proliferation  of Bone Marrow Cells Grafted into Irradiated  Mice 
Pretreated with Cydophosphamide* 
No.  of  Time  Mean splenic  uptake of lX~IUdR:~ 
Donor strain  cells  Recipient strain  after  in mice given 
grafted  CY  Saline  CY 
(X 10 6)  (days)  (% 4- sE) 
BI0  2.0  B10  1  0.43  :t= 0.07  0.45  4-  0.04 
2.0  B10  12  0.48  4- 0.10  0.42  4-  0.06 
2.3  B10.D2  1  0.03  4- 0.01  0.38  4- 0.06 
B10.D2  1.4  B10.D2  1  0.44  4- 0.05  0.27  4- 0.02 
DBA/2Ha  1.3  DBA/2Ha  1  1.07 4-  0.13  0.72  4-  0.03 
3.0  B10  1  0.09  4-4- 0.02  0.58  -4- 0.07 
2.0  (B10 x 129)F1  7  0.05  4- 0.02  0.78  4-  0.07 
2.0  C3BF1  7  0.02  0.78  4-  0.04 
2.0  C3BF1  14  0.02  0.24  4- 0.17 
2.0  C3BF1  21  0.02  0.02§ 
0.49  4- 0.52 
B10.A  2.3  C3BF1  1  0.02  0.40  -4- 0.05 
2.3  C3BF1  7  --  0.21  4-  0.07 
2.3  C3BF1  14  --  0.51  4-  0.10 
* Single intraperitoneal injection of 300 mg/kg of C¥ in saline. 
~: 4  days  after  irradiation  (800-900 R)  and transplantation. Radiation  control  values 
varied from 0.01 to 0.03% in mice of the strains used, at every interval after  CY. Mean 
radiation  control values were subtracted  from individual experimental values.  4-10  mice 
per group. 
§ Individual values in this group of six mice were 0.01, 0.01, 0.04, 0.19, 0.42, 1.46. 
grafting. CY pretreatment did not increase splenic retention of IUdR in radia- 
tion controls at any time interval tested.  1-14 days after C¥ administration, 
DBA/2 allografts grew in otherwise resistant B10,  (B10 x 129)F1,  and C3BF1 
hosts. At 21 days, half of the C3BF1 recipients were still susceptible, while the 
others  had  reacquired  resistance.  B10  allografts  grew  in  otherwise  resistant 
B10.D2 mice 1 day after injection of  CY. Likewise, B10.A allografts grew in 
otherwise resistant C3BF1 mice 1,  7,  and 14 days after injection of CY. Thus, 
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alter in a nonspecific way the ability of the host environment to support hemo- 
poietic proliferation, as indicated by IUdR uptake values in  spleens  of syn- 
geneic CY-treated recipients. 
It is noteworthy that another immunosuppressive agent,  rabbit anti-mouse 
thymocyte serum (ALS), prepared as described by Levey and Medawar  (12), 
failed to weaken resistance of C57BL mice to DBA/2Ha marrow grafts. 20 mice 
were  exposed  to  800  R  of X-rays;  one-half  were  injected  intraperitoneally 
with 0.5 ml of ALS and the remaining with normal rabbit serum  1 hr later. 
5 X  10  ~ nucleated marrow cells were grafted on the following day. Both serum 
treatments had no detectable effect on resistance, since IUdR uptake values 
in  recipient spleens were negligible 5  days after transplantation,  as in radia- 
tion controls. 
Weakening of Resistance to Marrow Allografts with Corynebacterium parvum.-- 
Since the immunosuppressive drug CY weakened the reaction of resistant mice 
to allogeneic hemopoietic cells, it was of interest to study the effect of a known 
"immunostimulant" on resistance. C. parvum produces in vivo a strong phago- 
cytic response (13), an adjuvant effect on antibody formation and on delayed 
hypersensitivity (14),  and an inhibitory effect on the growth of transplanted 
tumors (15,  16).  Furthermore, it increases the number of hemopoietic progeni- 
tor cells in the spleen (17), and presumably enhances in this way resistance of 
unirradiated F1 hybrid mice to graft-versus-host  mortality induced by parental 
lymphoid cells (18). 
Heat-killed cultures of C. parvum  (obtained through the courtesy of Dr. G. 
Biozzi) were suspended in saline,  and 0.5  mg  (dry weight)  of whole bacteria 
was  injected  intravenously into  prospective recipients  of  allogeneic marrow 
grafts. 7-13 days later the mice were irradiated (800-900 R) and grafted with 
0.56-1.12  X  106 cells.  The 7-13-day intervals were chosen because they coin- 
cided with  the  time of maximum phagocytic activity induced by C. parvum 
(13). Repopulation of recipient spleens was assessed 5 days after cell injection. 
In each experiment one group of mice was treated with C. parvum,  irradiated, 
but not injected with bone marrow cells,  to determine the background level 
of splenic retention of IUdR. Other groups of mice were treated with C. parvum, 
irradiated,  and grafted with syngeneic instead of allogeneic cells to determine 
whether C. parvum influenced grafted cell proliferation in the absence of histo- 
incompatibility. The results are presented in Table III. 
C57BL,  B10,  and  B10.D2  marrow  cells  grew  approximately the  same  in 
syngeneic mice given saline or C. parvum.  7-13 days after C. parvum adminis- 
tration,  allografts  of  cells  from these  three donor  strains  grew  in  otherwise 
resistant  hosts. Hence, resistance was weakened rather than enhanced by C. 
parvum.  Transplants  of more  than  106  cells  resulted  in  even greater splenic 
uptake of IUdR; at intervals of less than 6 days between C. parvum and graft- 
ing, the weakening effect on resistance was not observed (data not shown). 90  REJECTION  0~"  BONE  MARROW  ALLOGRAFTS 
In some additional  experiments,  the splenic retention  of IUdR was unusu- 
ally high  in  radiation  controls  given C.  parvum.  Presumably,  the number  of 
endogenous hemopoietic progenitor  cells was increased  before irradiation  (17) 
and the fraction of cells surviving irradiation repopulated  the spleens.  It was, 
therefore, necessary to obtain additional evidence that IUdR uptake in spleens 
of allogeneic graft recipients given C. pamum was due to proliferation of donor 
cells.  Spleen  cells  of chimera mice resulting from transplantation  of B10  cells 
into  irradiated  B10.A  hosts  given  C.  parvum  were  retransplanted  (one-half 
TABLE III 
Proliferation of Bone Marrow Cells Grafted into Irradiated Mice Pretreated 
with Corynebacterium parvum* 
I)onor 
strain 
C57BL 
B10 
B10.D2 
(X 109 I 
0.62  / 
0.56 
1.12 
Recipient strain 
C57BL 
DBA/2Ha ~ 
B10.D2 
B10.A 
B10.A 
B10 
B10.A 
B10.D2 
B10 
C3BF1 
(days) 
7 
7 
7 
8 
13 
13 
13 
8 
8 
10 
Mean splenic uptake of 1~sIUdR~ in mice given 
Saline  C. pamum 
(% 
0.63  4-  0.15  (8) 
0.04  ±  0.001  (11) 
001  (5) 
o.ol  (5) 
0.68  ±  0.06  (6) 
0.02  (8) 
0.32  ±  0.05  (5) 
0.02  (6) 
0.01  (5) 
-4- sE) 
0.71 
0.14 
0.31 
0.67 
0.12 
±  0.16  (10)§ 
±  0.004  (i4) 
±  0.03  (5) 
4-  0.39  (3) 
±  0.02  (4) 
0.60  ±  0.03  (6) 
0.33  ±  0.09  (9) 
0.38  4- 0.02  (6) 
0.32  4-0.04  (17) 
0.17  4-  0.005  (5) 
* Single intravenous injection of 0.5 mg (dry weight) of dead C. parvum suspended in saline. 
5 days after irradiation  (800-900 R) and transplantation.  Radiation control values varied 
from 0.02 to 0.04 in mice of the strains used, at every interval after C. parvum. Mean radiation 
control values were subtracted  from individual experimental values. 
§ Number of mice in brackets. 
spleen  equivalent)  on the 7th day into secondary irradiated  B10 hosts immu- 
nized  against  antigens  of B10.A.  In  this  two-step  transfer  experiment,  B10 
marrow cells ~  B10.A --~ B10, only donor cells could repopulate the secondary 
hosts and yield significant IUdR uptake.  8  of 10 spleens  of C. parvum-treated 
B 10.A recipients contained retransplantable  B l0 cells, while none of 10 spleens 
of untreated  B10.A recipients did.  The weakening of resistance  after adminis- 
tration of C. parvum was regarded as another evidence in favor of the concept 
that irradiated  mice can elicit destructive host anti-graft reactions. The effect 
of C. parvum also established  another difference between  the rejection  mecha- 
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Weakening of Resistance to Marrow Allografts by Sublethal Preirradialion.-- 
The lack of immediate sensitivity to radiation of this host anti-marrow allo- 
graft reaction could be explained in two ways: (a)  the effector cells were fixed 
and nondividing cells, such as neurons,  and simply not vulnerable to the anti- 
proliferative activity of  the  radiation doses used;  (b)  the  effector  cells were 
part of a  cell-renewal system, but  their function,  i.e. marrow graft rejection, 
was  not  radiosensitive. To  distinguish between  these  two  possibilities, mice 
resistant to allogeneic cells of given strains,  and syngeneic control mice, were 
TABLE IV 
Proliferation of 108 Transplanted Bone Marrow Cells in Mice Exposed to Split-Dose Irradiation 
Donor strain  Recipient strain  Exposures to  Interval  Mean splenic  uptake of  X-rays  between  125IUdR$ 
exposures* 
C57BL 
(days) 
B10  500  +  700  7  0.46  4- 0.06  (5)§ 
C57BL  700  --  0.43  4- 0,03  (3) 
B10.D2  500  +  700  7  0.24  4- 0,04  (5) 
B10,D2  700  --  0.01  (5) 
C57BL  C57BL  300  +  700  7  0.52  4- 0.07  (5) 
C57BL  400  +  700  7  0.60  4- 0.03  (8) 
C57BL  700  --  0.60  4- 0.15  (5) 
B10.BR  300  +  700  7  0.16  -4- 0.05  (6) 
B10.BR  400  +  700  7  0~14  4- 0.04  (7) 
B10.BR  700  --  0.02  (5) 
DBA/2Ha  C57BL/6  400  +  750  14  0.94  4- 0.25  (22) 
C57BL/6  750  --  0.01  (10) 
* Second exposure to X-rays preceded marrow grafting by a few hours. 
5 days after transplantation. Radiation control values varied from  0.01 to 0.03%  in 
mice  of the strains used after split-dose irradiation. Mean  radiation control values were 
subtracted from individual experimental values. 
§ Number of mice in brackets. 
exposed to sublethal irradiation (300-500 R) 7 or 14 days before a second expo- 
sure (700-900 R)  and challenge with marrow grafts of the appropriate strains. 
The results are reported in Table IV. 
106  C57BL  marrow  cells grew  approximately the same  on  transplantation 
into  preirradiated  or  untreated  syngeneic  recipients.  Preirradiation  of  allo- 
geneic  mice  weakened  resistance.  Proliferation  of  C57BL  cells  occurred  in 
otherwise  strongly resistant B10.D2  and  B10.BR  mice,  and  proliferation of 
DBA/2 cells occurred in preirradiated C57BL/6 mice. Additional experiments, 
not reported in Table IV, indicated that  the weakening of resistance did not 
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Transfer of Resistance and Susceptibility With A llogeneic Bone Marrow Cells.- 
The  decreased strength  of resistance several days after administration  of C. 
parvum or after exposure to sublethal doses of X-rays, and the late maturation 
of resistance in infant mice suggested that a population of host cells undergoing 
renewal is endowed with the ability to reject bone marrow allografts. To deter- 
mine whether  these  effector cells  belonged  to  the  hemopoietic system,  bone 
marrow cells  were  exchanged  between mice sharing  the  same H-2  allele but 
differing for resistance to a  third party graft. 
129-strain mice, susceptible to DBA/2 marrow cells,  were exposed to 750  or 
820 R  of X-rays in two separate experiments and were infused with  l0  T mar- 
row cells from either syngeneic or  C57BL  donors.  Mice of both  strains,  129 
and C57BL, are H-2  b homozygotes. Cell transfers were also done in the oppo- 
site  direction  in  two  other  experiments,  i.e.,  129  or  B10  marrow cells  were 
injected into irradiated B 10 recipients.  60-63  days later,  surviving mice were 
presumably blood chimeras. At this time the chimeras were exposed to radia- 
tion for the second time (700-800 R) and given a  test graft of 106 DBA/2Ha 
(11-2  a)  marrow cells.  Splenic  repopulation  was  assessed 5  days later.  A  fifth 
experiment with  C57BL/6  mice as recipients was done in a  similar way; the 
mice were initially  exposed to 400  R  of X-rays,  injected  with 4  X  106  129- 
strain or syngeneic marrow cells,  and challenged with DBA/2Ha cells 13 days 
later. The results are shown in Table V 
60-63  days after irradiation  and repopulation with syngeneic bone marrow 
cells,  129-strain  and B10 mice were as susceptible and resistant,  respectively, 
to DBA/2  grafts,  as untreated  control mice.  The B10  mice presumably lost 
resistance shortly after irradiation  and  transplantation  (Table IV),  but were 
reconstituted  by the  syngeneic graft.  The phenotype  of  129-strain  and  B10 
chimera mice repopulated  with  allogeneic  cells  changed.  129-strain  chimeras 
became resistant, whereas B10 chimeras became susceptible to DBA/2 grafts. 
The allogeneic chimeras assumed the phenotype of the donor's blood-forming 
tissue with  respect to resistance or susceptibility.  The same results  were ob- 
tained  when  C57BL/6  mice were repopulated with  fewer  129-strain  marrow 
cells  and  challenged  with  DBA/2  grafts  at  a  much  shorter  interval.  Bone 
marrow-derived cells conferred resistance or susceptibility in these experiments 
irrespective of the B10 or 129-strain environments, presumably by generating 
effector cells for DBA/2 graft rejection. 
In  contrast  to bone marrow cells,  serum did  not  passively transfer resist- 
ance.  129-strain susceptible mice and C3BF1 resistant mice (Tables II and V) 
were irradiated  (800  and  900  R,  respectively)  and  grafted  with  1.28  X  106 
marrow cells from DBA/2Ha donors.  18 hr later, at the time of graft rejection 
(see Fig. 2),  C3BF1 mice were bled and 0.5  ml of serum was injected into the 
peritoneal  cavity of  the  129-strain  recipients  of  DBA/2Ha  cells.  Untreated 
C3BF1 and irradiated C3BF1  mice not injected with DBA/2Ha cells were also GUSTAVO  CUDKOWICZ  AND  MICHAEL  BENNETT  93 
used as serum donors. None of the three sera influenced to any extent the growth 
of DBA/2Ha  cells in 129-strain mice.  Sera from resistant and  susceptible mice 
of several strains were not cytotoxic for marrow  cells of  appropriate  genotype 
in the presence of guinea pig or rabbit complement in vitro and in vivo. 
TABLE  V 
Cellular Transfer of Resistance and Susceptibility  to Bone Marrow Allografts; Proliferation of 
DBA /2 Test Grafts in Reciprocal C57BL to 129-Strain Chimeras* 
Induction of 
Chimerism 
Duration  Mean splenic  uptake of  Original  donor  Recipient strain  No. of  of 
strain  X-Ray  marrow  chimerism  12~IUdR:~ 
exposure  cells 
grafted 
(R)  (X 10  6)  (days)  (% +  sE) 
B10  129  750  10  63  0.08  ±  0.08  (5)§ 
129  750  10  63  0.57  ±  0.09  (9) 
None  --  --  --  0.35  ±  0.10  (7) 
C57BL/6  129  820  10  60  0.06  ±  0.10  (5) 
129  820  10  60  0.67  -4-  0.03  (4) 
None  --  --  --  0.42  -4-  0.14  (5) 
129  B10  750  10  63  0.22  -4-  0.07  (6) 
B10  750  10  63  0.01  (10) 
None  --  --  --  0.01  (5) 
129  B10  770  10  60  0.48  (2) 
B10  770  10  60  0.03  (8) 
None  --  --  --  0.04  (5) 
129  C57BL/6  400  4  13  0.71  -4-  0.25  (10) 
C57BL/6  400  4  13  0.05  ±  0.06  (6) 
None  --  --  --  0.01  (2) 
* Test grafts of 106 DBA/2 bone marrow cells were injected into chimeras and untreated 
control mice a few hours after exposure to 700-800 R  of X-rays. For the chimeras this was 
the second exposure to radiation. 
5 days after transplantation of DBA/2 cells.  Mean radiation control values were sub- 
tracted from individual experimental values. 
§ Numbers of mice in brackets. 
The Effect of Thymectomy on Differentiation of Effector Cells.--Since  rejection 
of marrow  allografts was  due to cells of  the hemopoietic system,  it became  of 
interest  to  determine  whether  differentiation  of  effector  cells  was  thymus 
dependent.  C57BL/6  and C3BF1 mice were  thymectomized  or sham  operated 
at 9  wk  of  age.  2  wk later,  the animals were  exposed  to  750-850  R  of X-rays 
and reconstituted with  107 syngeneic marrow  cells.  7  or 9  wk after reconstitu- 94  REJECTION  OF  BONE  MARROW  ALLOGRAFTS 
tion,  the mice were reexposed  to X-rays (750  R  for C57BL/6  and 900 R  for 
C3BF1) and challenged with DBA/2, WB, or BDF1 marrow allografts.  Splenic 
repopulation was assessed on the 4th day. Thymectomized and sham-operated 
C3BF~ mice were also given syngeneic test grafts to control that surgical pro- 
cedures did not interfere with splenic repopulation  (Table VI). Resistance was 
not  weakened  in  any  of  18  thymectomized  and  22  sham-operated  mice,  not 
TABLE VI 
Proliferation of Bone Marrow Test Grafts in Mice which were Thymectomized, Irradiated, and 
Reconstituted with Syngeneic Marrow 
Syngeneic chimera* 
Strain 
C57BL/6 
C3BF1 
C3BF1 
C3BF1 
C3BF1 
Pretreatment 
Sham Thy-X 
Thy  -X 
Sham Thy-X 
Thy-X 
Sham Thy-X 
Thy-X 
Sham Thy-X 
Thy-X 
Sham Thy-X 
Thy-X 
Strain 
DBA/2Ha 
DBA/2Ha 
WB 
BDF1 
C3BF1 
Test donor 
~ 
o. of 
ells 
gJ lfted 
lO s ) 
1 
1 
1.4 
1.4 
1.5 
1.5 
1.5 
1.5 
1.4 
1.4 
Mean splenic  uptake of 
12~IUdR$ 
(% ± sE) 
0.03  (5)§ 
0.01  (4) 
0.04  ±  0.01  (5) 
0.06  ±  0.01  (4) 
0.01  (4) 
0.01  (4) 
0.18  ::l: 0.03  (8) 
0.12  ±  0.07  (6) 
0.54  ±  0.08  (4) 
0.76  ±  0.08  (5) 
* Mice were thymectomized  (Thy-X) at the age of 9 wk; they were irradiated  (750-850 R) 
and reconstituted  with  l0  T syngeneic marrow cells 2 wk later. 
4 days after transplantation  of allogeneic or syngeneic test grafts. Mean radiation control 
values  were subtracted  from  individual  experimental  values.  Viability  of donor  cells was 
verified by transplantation  into syngeneic untreated  recipients (data not reported). 
§ Number of mice in brackets. 
even in the BDF1--+ C3BF1 combination in which resistance was partial. Hence, 
neither  inductive  nor  suppressive  thymic  influences  were  required  in  adult 
mice for differentiation  of the marrow-derived effector cells. 
Time of Rejection of BIO Marrow Allografts  by Irradiated Resistant Hosts.- 
Viable  marrow  cells  grafted  into  irradiated  allogeneic  resistant  mice  did  not 
generate  proliferating  progeny  within  4-5  days.  Graft  failures  could  have 
resulted either from killing of the hemopoietic progenitor cells of donor origin, 
i.e.  rejection,  or from inhibition  of donor cell proliferation  and differentiation 
without  killing.  To  test  for  survival  of  donor  cells  in  spleens  of  irradiated GUSTAVO  CUDKOWICZ  AND  MICHAEL  BENNETT  95 
resistant mice, the spleens were sampled  3-120 hr  after transplantation  and 
retransplanted into irradiated secondary recipients syngeneic with the original 
marrow  donor.  The  secondary  recipients  were  actively  immunized  against 
antigens  of  the  primary recipients which  were  resistant  to  the  donor  cells. 
2.5  X  106 B10  marrow cells were transplanted  into  each irradiated  (800 R) 
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FIG. 2.  Recovery of retransplantable B10 hemopoietic cells from the spleens of recipient 
mice at  various times after  transplantation of 2.5  X  106 marrow cells. Primary recipients 
were mice of strains B 10 (syngeneic with donor cells), B 10.D2, B 10.BR, and B 10.A (aUogeneic 
with and resistant to donor cells). Points represent the percentages of cells recovered from the 
whole spleens of individual primary recipients, as estimated by retransplantation  into sec- 
ondary B10 recipients. The  100%  value was estimated from primary B10  recipients given 
2.5 X  10  5 marrow cells. 
mouse of the following strains: B10(syngeneic), B10.D2, B10.BR, and BI0.A 
(allogeneic with and resistant to B 10).  Female and male mice were used, but 
sexes of donors and recipients were always matched. At the intervals indicated 
in  Fig.  2,  primary recipient mice were killed  and  the  spleen  cells dispersed 
to determine the content of retransplantable donor-type hemopoietic cells.  All 
secondary B10 hosts were exposed to 800 R  of X-rays and each mouse was 
grafted with the cells  of one whole primary recipient spleen; these B10 mice 
were  preimmunized  against  B10.D2,  B10.BR,  or  B10.A  alloanfigens  (or 96  REJECTION  OF  BONE  MARROW  ALLOGRAFTS 
injected with B 10 spleen ceils)  before irradiation depending upon the strain of 
the  primary  recipients.  Proliferation  of  donor-type  hemopoietic  cells  was 
assessed in secondary recipients 5  days after retransplantation.  For each ex- 
periment a group of irradiated B10 mice was injected with 2.5  X  105 marrow 
cells  of the original donor cell preparation instead  of 2.5  X  l0  s,  to measure 
proliferation  of progenitor  cells  in  terms  of  5  day  splenic  uptake  of IUdR 
without retransplantation.  The mean value so obtained was multiplied by 10 
to estimate the value of splenic uptake of IUdR which would have been ob- 
tained in  secondary hosts  if  100%  of progenitor cells injected into primary 
recipients could have been recovered. The percentages of cells actually recov- 
ered from each of the 70 syngeneic and 79 resistant primary recipient mice are 
shown in Fig. 2. 
During  the first  12 hr after transplantation  of B10 marrow cells into syn- 
geneic mice, only a small percentage of the injected progenitor cells was recov- 
ered from the host spleens. With increasing time, recovery tended to decrease 
with a nadir at  18 hr. Afterwards, recovery increased at an exponential rate, 
owing  to  replication  and  differentiation of  transplanted  stem  cells  (17).  In 
allogeneic hosts resistant to B10 marrow grafts, recovery of hemopoietic cells 
was comparable to that in syngeneic hosts for the first 18 hr. At 24 hr a small 
fraction  of  transplanted  ceils,  approximately  1%,  was  still  reproductively 
viable.  At  this  time,  however,  recovery was  less  from  the  spleens  of most 
resistant hosts than from B10 mice. At later intervals the discrepancy between 
B10 and resistant mice became greater owing to expansion of hemopoietic cell 
numbers in the former and loss of cells  in the latter.  B10 stem cells did not 
proliferate or differentiate in allogeneic resistant mice, since neither new pro- 
genitor cells nor differentiating descendents were produced. Stem cells also did 
not survive beyond 96 hr. In view of the possible survival and function of B10 
stem  cells  in  infant  allogeneic mice  or in  adults  whose resistance had  been 
weakened  (Tables  II-IV),  it  is  concluded  that  the  B10  cells were  actually 
rejected beginning 18-24 hr after transplantation. 
DISCUSSION 
The failure of transplanted bone marrow cells  to engraft in irradiated but 
otherwise untreated allogeneic mice of certain strains is due to an active host 
anti-graft reaction directed specifically against hemopoietic target cells bearing 
H-2 alloantigens. This conclusion is primarily based on the following observa- 
tions: (a) graft failure can be prevented by several kinds of host pretreatments 
which are either anti-proliferative and cytocidal (cyclophosphamide, split-dose 
irradiation), or intensely stimulating to the reticular system (C. parvum);  (b) 
marrow graft failure does not  occur in  infant mice during  the  2nd  and  3rd 
week of life;  (c)  mice of resistant  and susceptible strains  are equally incom- 
patible to skin and other solid tissue allograffs, irrespective of whether sus- GUSTAVO  CUDKOW[CZ  AND  MICHAEL  BENNETT  97 
ceptibility to bone marrow was a genetic trait or induced by C. parvum (6,  15, 
16); (d) for marrow graft failure to occur the donor and recipient strains must 
differ at the major histocompatibility locus//-2,  but not necessarily at other 
minor/t loci. 
A  limited survey of 14 inbred mouse strains for resistance to marrow allo- 
grafts after whole body irradiation clearly indicated that the outcome of the 
grafts was extremely variable and not predictable by the//-2 alleles of donor 
and  recipients.  //-2  incompatibility was  a  necessary but  not  sufficient pre- 
requisite for resistance to marrow grafts in several host-donor combinations. 
For example, mice of three tl-2  k strains, C3H, AKR, and 101, were susceptible 
to B10 grafts, while mice of two others, C57BR and B10.BR, were not. It is 
to be noted that the B10.BR strain was congenic with B10, thus differing from 
the donor strain  only at  the  //-2  locus.  However, host-donor differences at 
several other minor//loci (with or without//-2 differences) did not result in 
marrow graft failure in host mice of the congenic pair C3H (H-2  k) and C3H.SW 
(/t-2  b)  given B10 cells.  The variable outcome of B10 grafts in series of allo- 
geneic  recipient  strains  of  the  same  //-2  type  indicated  that  other  genetic 
factors controlled recognition of,  or reactivity to, //-2 alloantigens  of hemo- 
poietic cells,  or both. The same could be said for B10 grafts in mice of 1t-2  a 
and//-2  d strains, and for DBA/2 grafts in mice of H-2  k and H-2  b strains (Fig. 
1). The interstrain variation and the dominant inheritance of resistance by F1 
mice in five different crosses strongly supported this view. Since mice of given 
strains were not universal acceptors or rejectors of H-2-incompatible grafts, the 
genetic factors involved were determinant specific and presumably controlled 
recognition rather than reactivity. Resistant  or susceptible phenotypes were 
expressed by marrow-derived host cells and not by other cell types or by the 
environment.  These  features  of  marrow  graft  rejection  resemble  those  of 
specific  antibody  responses  to  natural  and  synthetic  antigens  regulated  by 
immune  response  (Ir)  genes (19)  and those of resistance to leukemogenic vi- 
ruses controlled by the Fv-1 gene (20). Accordingly, mice resistant to marrow 
allografts  could  be  regarded  as  genetic  "responders,"  susceptible  mice  as 
"nonresponders," and partially resistant mice as "poor responders." 
It has been emphasized that Ir genes are closely linked with, or an integral 
part of, H  genes (19, 21-23), and that the broader category of genes regulating 
defense reactions may also be functionally related to H  loci (24). Recognition 
of antigens,  alloantigens,  and viruses may be influenced by patterns  on cell 
surfaces specified by H  genes. If this were the case for certain chromosomal 
regions  regulating  marrow  graft  rejection,  one  would  expect  inbred  mouse 
strains  of common ancestry and with relatively small degree of diversity for 
H  Mleles  to  exhibit  limited  diversity also  for  resistance  or  susceptibility to 
given H-2-incompatible grafts,  and vice versa. According to the survey pre- 
sented in Fig. 1, most strains resistant to B10 and DBA/2 grafts belong to the 98  REJECTION  OF  BONE  MARROW  ALLOGRAFTS 
ancestry group with minimal diversity for minor/-/loci, identified as group 
No. 2 by Graft and Snell (25).  Conversely, the susceptible strains belong either 
to ancestry group No.  1 of greater diversity or to ancestry group No. 3. Irre- 
spective of whether certain minor H  genes themselves or/-/-linked genes regu- 
lated marrow graft rejection, these studies showed that donor and host strains 
do not have to differ at these loci. It is tempting to speculate that congruence 
of critical cell surface areas, such as those specified by minor/-/genes, would 
facilitate recognition of incongruent areas containing II-2 alloantigens. From 
the  survey made it  appeared  that  host resistance was  stronger for marrow 
allografts of congenic donors differing only at the I-I-Z region than for marrow 
grafts  of unrelated  strains.  The number  of  determinant-specific genes regu- 
lating  marrow  graft  rejection  in  the  susceptible-resistant  pairs  C3H/He- 
B10.BR and B10-129  (grafted with B10  and DBA/2  cells,  respectively) was 
tentatively estimated to be a  minimum of two for each pair (26). 
In addition to the peculiar genetics, physiologic parameters of marrow allo- 
graft rejection  are  also  unlike those of other  transplantation reactions.  The 
persistence of reactivity after 700-900  R  of whole body X-irradiation and the 
rapid onset of rejection 24 hr after transplantation are indirect evidence that 
host cell proliferation is not required. Relative radio-resistance is not so unusual 
for cell-mediated immune responses since delayed-type hypersensitivity reac- 
tions (27, 28),  normal lymphocyte transfer reactions  (29),  and production of 
homocytotropic antibody (30)  develop after radiation  exposures  suppressive 
for production of other humoral antibodies. If cellular proliferation does not 
take place between marrow grafting and rejection, effector cells endowed with 
specificity could be induced directly by antigenic cells as a final step in matura- 
tion. However,  effector cells  could be generated independently of antigen in 
the course of the normal cellular differentiation, maturation, and proliferation 
of the immune system (31).  The  "spontaneous" maturation of resistance in 
infant mice of responder strains, and the weakening of resistance by preirradia- 
tion of prospective recipients or by their pretreatment with C. parvum indicated 
that at least all but the final step in differentiation are antigen independent. 
"Spontaneous"  occurrence  of  delayed-type hypersensitivity to  alloantigens 
has been described in guinea pigs by Battisto (32). 
The transfer with bone marrow cells  of resistance and susceptibility to ir- 
radiated hosts  of opposite phenotype is taken as evidence that effector cells 
for marrow graft rejection are derived from bone marrow, as are effector cells 
in delayed hypersensitivity (33, 34)  and in skin graft rejection  (35).  Differen- 
tiation of effector cells is thymus independent both for marrow graft rejection 
and  for  delayed-type hypersensitivity reactions  (33).  However,  the  former, 
unlike the latter,  do not require  thymus-derived cells  even for  initiation of 
marrow graft rejection. The effector cells presumably are not phagocytes since 
C. parvurn  weakens resistance at the time of enhanced phagocytic activity. It tllIJI  I~RI(~P~  t~M~TAt  C--~J~TRI 
9roeV  61.  It  ? 
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is possible that the unexpected effect of C. parvum on resistance was due to 
exhaustion or diversion of common precursors of phagocytes, lymphoid cells, 
and effector ceils.  The bone marrow origin of cells  responsible for graft rejec- 
tion is consistent with the results of tests in which allogeneic fibroblastic cells 
were killed in vitro by irradiated lymphoid cells of thymectomized irradiated 
mice reconstituted with marrow (36). 
Marrow allograft failures in irradiated hosts could have resulted from prop- 
erties inherent to the transplanted cells rather than to host reactivity. Specifi- 
cally,  lymphoid  cells  of  transplanted  marrow  could  have  engaged  in  graft- 
versus-host  reactions  and  destroyed  bystander  hemopoietic  stern  cells  (7). 
This was unlikely because mouse bone marrow grafts do not cause acute graft- 
versus-host  reactions.  However,  the  optimal  growth  of  marrow  allografts  in 
infant mice,  which  are  exquisitely sensitive  to graft-versus-host  disease,  and 
the similar fate of transplanted marrow and graft-versus-host  cells in responder 
and  nonresponder  mice  (4),  make  this  hypothesis  untenable.  The  so-called 
phenomenon of allogeneic inhibition  (8),  by which cells  die after exposure to 
ailoantigens,  failed to occur in nonresponder mice and in young or appropri- 
ately pretreated adult responder mice. It cannot explain, therefore, the resist- 
ance of irradiated responder mice to bone marrow allografts. 
SUMMARY 
Mice are capable of rejecting H-2-incompatible bone marrow grafts after a 
single lethal exposure to X-rays. The onset of rejection begins 18-24 hr after 
transplantation and is completed by 96 hr. Maturation of this type of allograft 
reactivity does not occur until the 22nd day of life. In adult mice, the resist- 
ance to marrow allografts  can be weakened by administration  of cyclophos- 
phamide  or  dead  cultures  of Corynebacterium parvum,  but  not  heterologous 
anti-thymocyte serum. Sublethal exposures to X-rays 7 or 14 days before trans- 
plantation  also weaken resistance. There is  considerable interstrain variation 
in the ability of mice to resist allografts, even when H-2 differences between 
hosts and donor are kept identical. Although H-2 incompatibility is a necessary 
prerequisite for resistance, additional genetic factors influence the outcome of 
marrow allografts, presumably by controlling recognition. The regulator genes 
are determinant  specific  and  the  alleles  for  resistance  or  responder  status 
appear to be dominant. The responder phenotype is expressed by hemopoietic 
ceils and not by the environment. Accordingly, resistance is conferred to other- 
wise susceptible mice upon transfer of bone marrow cells but not of serum. The 
production  and  differentiation  of  effector  ceils  for  marrow  graft  rejection 
are  thymus independent. 
In  conclusion,  bone  marrow  allografts  elicit  a  particular  transplantation 
reaction,  previously unknown,  in  irradiated  mice.  Peculiar  features  of  this 
reaction are the lack of proliferation of host lymphoid cells,  tissue specificity, 100  REJECTION  OF  BONE  MARROW  ALLOGRAI~TS 
thymus independence,  and regulation  by genetic factors which apparently  do 
not affect the fate  of other grafts. 
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